Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ketamine 500mg/10ml solution for injection vials
1501010F0AAABAB
|
Ketamine (Anaesthesia) | Ketamine | Anaesthesia | 35 |
|
Ketamine 200mg/20ml solution for injection vials
1501010F0AAAAAA
|
Ketamine (Anaesthesia) | Ketamine | Anaesthesia | 16 |
|
Ketamine 50mg/5ml solution for injection ampoules
1501010F0AAAEAE
|
Ketamine (Anaesthesia) | Ketamine | Anaesthesia | 2 |
|
Ketamine 100mg/2ml solution for injection ampoules
1501010F0AAAFAF
|
Ketamine (Anaesthesia) | Ketamine | Anaesthesia | No data available |
|
Ketamine 1g/10ml solution for injection vials
1501010F0AAADAD
|
Ketamine (Anaesthesia) | Ketamine | Anaesthesia | No data available |
|
Ketamine 25mg/5ml solution for injection ampoules
1501010F0AAAGAG
|
Ketamine (Anaesthesia) | Ketamine | Anaesthesia | No data available |
|
Ketamine 50mg/2ml solution for injection ampoules
1501010F0AAAHAH
|
Ketamine (Anaesthesia) | Ketamine | Anaesthesia | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.